Epidemiology of inflammatory bowel disease: An update

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 5, 1996, Pages 417-427

  Russel, Maurice G V M ^a   Stockbrügger, Reinhold W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CROHN DISEASE; ENTERITIS; ETHNOLOGY; HUMAN; INCIDENCE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

EID: 0029988890     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609006759     Document Type: Review

References (190)

1. Kildebo S, Nordgaard K, Aronsen O, Breckan R, Burhol PG, Jorde R, et al. The incidence of ulcerative colitis in Northern Norway from 1983 to 1986. Scand J Gastroenterol 1990; 25:890-6.
2. Kildebo S, Breckan R, Nordgaard K, Burhol PG, Jorde R, Members of the Northern Norway Gastroenterology Society. The incidence of Crohn's disease in northern Norway from 1983 to 1986. Scand J Gastroenterol 1989;24:1265-70.
3. Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992;27:609-14.
4. Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26: 1247-56.
5. Stonnington CM, Phillips SF, Melton LJ, Zinsmeister AR. Chronic ulcerative colitis: incidence and prevalence in a community. Gut 1987;28:402-9.
6. Stowe SP, Redmond SR, Stormont JM, Shah AN, Chessin LN, Segal HL, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 1990;98:104-10.
7. Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991;100:350-8.
8. Kyle J. Crohn's disease in the northeastern and northern Isles of Scotland: an epidemiological review. Gastroenterology 1992;103:392-9.
9. Martinez Salmeron JF, Rodrigo M, de Teresa J, Nogueras F, Garcia Montero M, de Sola C, et al. Epidemiology of inflammatory bowel disease in the province of Granada, Spain: a retrospective study from 1979 to 1988. Gut 1993;34:1207-9.
10. Tragnone A, Hanau C, Bazzocchi G, Lanfranchi GA. Epidemiological characteristics of inflammatory bowel disease in Bologna, Italy - incidence and risk factors. Digestion 1993;54:183-8.
11. Vucelic B, Korac B, Sentic M, Milicic D, Hadzic N, Juresa V, et al. Ulcerative colitis in Zagreb, Yugoslavia: incidence and prevalence 1980-1989. Int J Epidemiol 1991;20:1043-7.
12. Cottone M, Cipolla C, Orlando A, Oliva L, Aiala R, Puleo A. Epidemiology of Crohn's disease in Sicily: a hospital incidence study from 1987 to 1989. The Sicilian Study Group of Inflammatory Bowel Disease'. Eur J Epidemiol 1991;7: 636-40.
13. Vucelic B, Korac B, Sentic M, Milicic D, Hadzic N, Juresa V, et al. Epidemiology of Crohn's disease in Zagreb, Yugoslavia: a ten-year prospective study. Int J Epidemiol 1991;20:216-20.
14. Ruiz V. Crohn's disease in Galicia, Spain. Scand J Gastroenterol 1989;24 Suppl 170:29-31.
15. Manousos ON, Triantaphyllidis I, Emmanouilidis A, Papademitriou C. Ulcerative colitis in Greece. Epidemiologic and clinical data. Scand J Gastroenterol 1989;24 Suppl 170: 25-6.
16. Lee FI, Costello FT. Crohn's disease in Blackpool - incidence and prevalence 1968-80. Gut 1985;26:274-8.
17. Mayberry JF. Crohn's disease in developing countries. Ital J Gastroenterol 1980;12:324-6.
18. Mayberry JF, Mann R. Inflammatory bowel disease in rural sub-Saharan Africa: rarity of diagnosis in patients attending mission hospitals. Digestion 1989;44:172-6.
19. Kurata JH, Kantor Fish S, Frankl H, Godby P, Vadheim CM. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology 1992;102:1940-8.
20. Jayanthi V, Chuah SY, Probert CSJ, Mayberry M, Mayberry JF. Proctitis and proctosigmoiditis - a need to identify the extent of disease in epidemiological surveys. Digestion 1993;54:61-4.
21. Calkins BM, Mendeloff AI. The epidemiology of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. 4th ed. Baltimore: Williams & Wilkins, 1995:31-70.
22. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991;100:143-9.
23. Binder V. Progress in epidemiology, quality of life and life expectancy in IBD. In: Tijtgat GNJ, Bartelsman JFWM, Deventer van SJH, editors. Inflammatory bowel disease. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1995:27-32.
24. Thomas GA, Millar-Jones D, Rhodes J, Roberts GM, Williams GT, Mayberry JF. Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol 1995;7:401-6.
25. Sandler RS. Epidemiology of inflammatory bowel disease. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease; from bench to bedside. Baltimore (MD): Williams & Wilkins, 1994:5-32.
26. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative proctitis in central Sweden 1965-1983. A population-based epidemiological study. Dig Dis Sci 1991;36:97-102.
27. Srivastava ED, Mayberry JF, Morris TJ, Smith PM, Williams GT, Roberts GM, et al. Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut 1992;33:256-8.
28. Berner J, Kiaer T. Ulcerative colitis and Crohn's disease on the Faroe Islands 1964-83. A retrospective epidemiological survey. Scand J Gastroenterol 1986;21:188-92.
29. Róin F, Róin J. Inflammatory bowel disease of the Faroe Islands, 1981-1988. A prospective epidemiologic study: primary report. Scand J Gastroenterol 1989;24 Suppl 170:44-6.
30. Mendeloff AI. The epidemiology of chronic IBD. In: Järnerot G, editor. Inflammatory bowel disease. Malmo: Corona, 1992:15-35.
31. Burch RPJ, de Dombal FT, Watkinson G. Aetiology of ulcerative colitis. II. A new hypothesis. Gut 1969;10:277-84.
32. Haug K, Schrumpf E, Halvorsen JF, Fluge G, Hamre E, Hamre T, et al. Epidemiology of Crohn's disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway. Scand J Gastroenterol 1989;24:1271-5.
33. Haug K, Schrumpf E, Barstad S, Fluge G, Halvorsen JF. Epidemiology of ulcerative colitis in western Norway. Scand J Gastroenterol 1988;23:517-22.
34. Rhodes J, Rose JD. Crohn's disease in the elderly [editorial]. Br Med J Clin Res 1985;291:1149-50.
35. Devlin HB, Datta D, Dellipiana AW. The incidence and prevalence of inflammatory bowel disease in North Tees Health District. World J Surg 1980;4:183-93.
36. Binder V. Epidemiology, course and socio-economic influence of inflammatory bowel disease. Schweiz Med Wochenschr 1988;118:738-42.
37. Rogers BHG, Clark LM, Kirsner JB. The epidemiology and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chron Dis 1971;24:743-73.
38. Morson BC. Pathology of ulcerative colitis. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. Philadelphia: Lea & Febiger, 1980:281-95.
39. Whitehead R. Pathology of Crohn's disease. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. Philadelphia: Lea & Febiger, 1980:293-307.
40. Calkins BM, Mendeloff AI. Epidemiology of inflammatory bowel disease. Epidemiol Rev 1986;8:60-91.
41. Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984;29:913-20.
42. Mayberry JF, Rhodes J. An international study of mortality from inflammatory bowel disease. Digestion 1982;244:73-8.
43. Binder V. Prognosis and quality of life in patients with ulcerative colitis and Crohn's disease. Int Disabil Stud 1988;10:172-4.
44. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:158-63.
45. Weterman IT, Biemond I, Pena AS. Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University hospital. Gut 1990;31:1387-90.
46. Ekbom A, Hemlick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population based study. Gastroenterology 1992;103:954-60.
47. Weldon MJ, Maxwell JD. Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy? Gut 1994;35:867-71.
48. Lochs H. Consequences of aetiological hypotheses for the treatment of IBD. In: Schölmerich J, Kruis W, editors. IBD, pathophysiology as a basis of treatment. Dordrecht: Kluwer Academic Publishers, 1993:30-5.
49. Wright JP, Froggatt J, O'Keefe EA, Ackerman S, Watermeyer S, Louw J, et al. The epidemiology of inflammatory bowel disease in Cape Town 1980-1984. S Afr Med J 1986;70: 10-5.
50. Wright JP, Marks IN, Jameson C, Garisch JA, Burns DG, Kottler RE. Inflammatory bowel disease in Cape Town, 1975-1980. II. Crohn's disease. S Afr Med J 1983;63:226-9.
51. Wright JP, Marks IN, Jameson C, Garisch JA, Burns DG, Kottler RE. Inflammatory bowel disease in Cape Town, 1975-1980. I. Ulcerative colitis. S Afr Med J 1983;63:223-6.
52. Monk M, Mendeloff AI, Siegel CI, Lilienfeld AM. An epidemiological study of ulcerative colitis and regional enteritis among adults in Baltimore. Hospital incidence and prevalence 1960-1963. Gastroenterology 1967;53:198-210.
53. Odes HS, Fraser D, Krawiec J. Incidence of idiopathic ulcerative colitis in Jewish population subgroups in the Beer Sheva region of Israel. Am J Gastroenterol 1987;82:854-8.
54. Rozen P, Zonis J, Yekutiel P, Gilat T. Crohn's disease in the Jewish population of Tel-Aviv-Yafo. Gastroenterology 1979; 76:25-30.
55. Odes HS, Locker C, Neumann L, Zirkin HJ, Weizman Z, Sperber AD, et al. Epidemiology of Crohn's disease in southern Israel. Am J Gastroenterol 1994;89:1859-62.
56. Grossman A, Fireman Z, Lilos P, Novis B, Rozen P, Gilat T. Epidemiology of ulcerative colitis in the Jewish population of central Israel 1970-1980. Hepatogastroenterology 1989;36: 193-7.
57. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992;33:687-93.
58. Jayanthi V, Probert CS, Pinder D, Wicks AC, Mayberry JF. Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q J Med 1992;82: 125-38.
59. Jayanthi V, Probert CS, Pollock DJ, Baithun SI, Rampton DS, Mayberry JF. Low incidence of ulcerative colitis and proctitis in Bangladeshi migrants in Britain. Digestion 1992; 52:34-42.
60. Singer HC, Anderson JGD, Frischer H, Kirsner JB. Familial aspects of IBD. Clin Gastroenterol 1980;9:271-7.
61. Yang HY, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993; 34:517-24.
62. Roth MP, Petersen GM, McElree C, Feldman E, Rotter JI. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989;97:900-4.
63. Tysk C, Riedesel H, Lindberg E, Panzini B, Podolsky D, Järnerot G. Colonic glycoproteins in monozygotic twins with inflammatory bowel disease. Gastroenterology 1991;100: 419-23.
64. Yang HY, Rotter JI. Genetic aspects of idiopathic inflammatory bowel disease. In: Kirsner JB, editor. Inflammatory bowel disease. 4th ed. Philadelphia: Lea & Febiger, 1993.
65. Yang HY, Rotter JI. The genetics of inflammatory bowel disease: genetic predisposition, disease markers, and genetic heterogeneity. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore (MD): Williams & Wilkins, 1994:32-64.
66. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993;104: 741-8.
67. Oudkerk Pool M, Roca M, Reumaux D, Bouma G, Pena AS, Colombel JF, et al. The value of P-Anca as a serological marker for ulcerative colitis in different European regions. Eur J Gastroenterol Hepatol 1994;6:399-403.
68. Shanahan F, Duerr RH, Rotter JI, Yang HY, Sutherland LR, McElree C, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992;103:456-61.
69. Reumaux D, Colombel JF, Delecourt L, Noel LH, Cortot A, Duthilleul P. Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in patients with ulcerative colitis (UC): influence of disease activity and familial study. Adv Exp Med Biol 1993;336:515-8.
70. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmatic antibodies in ulcerative colitis, comparison with other colitides, diarrhoeal illness. Gastroenterology 1991;100:1590-6.
71. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of anti-neutrophil cytoplasmatic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
72. Shanahan F, Landers C, Duerr RH, Targan SR. Neutrophil autoantibodies as disease markers for ulcerative colitis. Immunol Res 1991;10:479-84.
73. Seibold F, Klein R, Slametchka D, Weber P, Berg P, Gregor M. P-Anca in family members of patients with ulcerative colitis and PSC. Gastroenterology 1993;104:A778.
74. Yang P, Järnerot G, Danielsson D, Tysk C, Lindberg E. P-Anca in monozygotic twins with inflammatory bowel disease. Gut 1995;36:887-90.
75. Yang HY, Rotter JI, Toyoda H, Landers C, Tyran D, McElree CK, et al. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993;92:1080-4.
76. Harries AD, Baird A, Rhodes J, Mayberry JF. Has the rising incidence of Crohn's disease reached a plateau? Br Med J 1982;284:235.
77. Miller DS, Keighley A, Smith PG, Hughes AO, Langman MJ. Crohn's disease in Nottingham: a search for time-space clustering. Gut 1975;16:454-7.
78. Cave DR, Freedman LS. Seasonal variation in clinical presentation of Crohn's disease and ulcerative colitis. Int J Epidemiol 1975;4:317-20.
79. Tysk C, Järnerot G. Seasonal variation in exacerbations of ulcerative colitis. Scand J Gastroenterol 1993;28:95-6.
80. Don BA, Goldacre MJ. Absence of seasonality in emergency hospital admissions for inflammatory bowel disease [letter]. Lancet 1984;2:1156-7.
81. Comes MC, Gower Rousseau C, Colombel JF, Belaiche J, Van Kruiningen HJ, Nuttens MC, et al. Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liege county of Belgium. Gut 1994;35:1316-8.
82. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
83. Sanderson IR, Hermon-Taylor J. Mycobacterial disease of the gut: some impact from molecular biology. Gut 1992;33: 145-7.
84. Sanderson JD, Moss MT, Malik ZP, Tizard ML, Green EP, Hermon Taylor J. Polymerase chain reaction detects mycobacterium paratuberculosis in Crohn's disease tissue extracts [abstract]. Gut 1991;32:A572.
85. Burnham WR, Lennard-Jones JE, Stanford JL, Bird RG. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 1978;2:693-6.
86. Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA. Spheroblastic phase of mycobacteria isolated from patients with Crohn's disease. J Clin Microbiol 1986;24:357-63.
87. Jewell DP. Pathogenesis of Crohn's disease: the environment revisited. Eur J Gastroenterol Hepatol 1995;7:383-4.
88. Prantera C, Kohn A, Mangiarotti R, Andreoli A, Luzi C. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen. Am J Gastroenterol 1994;89:513-8.
89. Graham DY, Al-Assi MT, Robinson M. Prolonged remission in Crohn's disease following therapy for mycobacterium Paratuberculosis [abstract]. Gastroenterology 1995;108:A826.
90. Afdhal NH, Long A, Lennon J, Crowe J, O'Donoghue DP. Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo. Dig Dis Sci 1991;36: 449-53.
91. Swift GL, Srivastava ED, Stone R, Pullan RD, Rhodes J, Wilkinson S, et al. Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease. Gut 1994;35: 363-8.
92. Schaffer JL, Hughes S, Linaker BD, Baker RD, Turnberg LA. Controlled trial of rifampicin and ethambutol in Crohn's disease. Gut 1984;25:203-5.
93. Farmer GW, Vincent MM, Fucillo DA. Viral infection in ulcerative colitis and regional enteritis. Gastroenterology 1973; 65:8-18.
94. Ekbom A, Wakefield AJ, Zack M, Adami HO. Perinatal measles infection and subsequent Crohn's disease. Lancet 1994;344:508-10.
95. Ekbom A, Adami HO, Helmick CG, Jonzon A, Zack MM. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol 1990;132:1111-9.
96. Wakefield AJ, Pittilo RM, Sim R. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993; 39:345-53.
97. Thompson NP, Pounder RE, Wakefield AJ. Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur J Gastroenterol Hepatol 1995;7:385-95.
98. Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995;345:1071-4.
99. Thornton JR, Emmet PM, Heaton KW. Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J 1979;2:762-4.
100. Kasper H, Sommer H. Dietary fibre and nutrient intake in Crohn's disease. Am J Clin Nutr 1979;32:1898-901.
101. Mayberry JF, Rhodes J, Newcombe RG. Increased sugar consumption in Crohn's disease. Digestion 1980;20:323-6.
102. Thornton JR, Emmett PM, Heaton KW. Diet and ulcerative colitis. BMJ 1980;280:293-4.
103. Tragnone A, Valpiani D, Miglio F, Elmi G, Bazzocchi G, Pipitone E, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:47-51.
104. Järnerot G, Jarnmark I, Nilsson K. Sugar consumption in Crohn's disease, ulcerative colitis or irritable bowel disease. Scand J Gastroenterol 1983;18:999-1002.
105. Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992;3: 47-52.
106. Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987;22:1009-24.
107. Panza E, Franchesi S, La Vecchia S, Parranzini F, Petrillo M, Decarli A, et al. Dietary factors in the aetiology of inflammatory bowel disease. Ital J Gastroenterol 1987;19: 205-9.
108. Järnerot G. Dietary factors in inflammatory bowel disease. In: Järnerot G, Lennard-Jones JE, Truelove SC, editors. Inflammatory bowel disease. Malmö: Corona Astra, 1992:53-60.
109. Koletzko S, Griffiths A, Corey M, Smith C, Sherman P. Infant feeding practices and ulcerative colitis in childhood. Br Med J 1991;302:1580-1.
110. Koletzko S, Sherman P, Corey M, Griffiths A, Smith C. Role of infant feeding practices in development of Crohn's disease in childhood. Br Med J 1989;298:1617-8.
111. Rigas A, Rigas B, Glassman M, Yen YY, Lan SJ, Petridou E, et al. Breast-feeding and maternal smoking in the etiology of Crohn's disease and ulcerative colitis in childhood. Ann Epidemiol 1993;3:387-92.
112. Levine J. Exogenous factors in Crohn's disease. A critical review. J Clin Gastroenterol 1992;14:216-26.
113. Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut 1990;31: 1037-40.
114. Sandler RS, Golden AL. Epidemiology of Crohn's disease. J Clin Gastroenterol 1986;8:160-5.
115. Whybrow PC, Kane FJ, Lipton MA. Regional ileitis and psychiatric disorder. Psychosom Med 1968;30:209-21.
116. Cohn EM, Lederman II, Shore E. Regional enteritis and its relation to emotional disorders. Am J Gastroenterol 1970;54: 378-87.
117. Goldberg D. A psychiatric study of patients with diseases of the small intestine. Gut 1970;11:459-65.
118. Helzer JE, Chammas S, Norland CC, Stillings WA, Alpers DH. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology 1984;86:324-30.
119. Clouse RE, Alpers DH. The relationship of psychiatric disorder to gastrointestinal illness. Annu Rev Med 1986;37:283-95.
120. Schwartz SP, Blanchard EB. Inflammatory bowel disease: a review of the psychological assessment and treatment literature. Ann Behav Med 1990;12:95-105.
121. Duffy LC, Zielezny MA, Marshall JR, Weiser MM, Phillips JF, Byers TE, et al. Lag time between stress events and risk of recurrent episodes of inflammatory bowel disease. Epidemiology 1991;2:141-5.
122. Jick H, Walker AM. Cigarette smoking and ulcerative colitis. N Engl J Med 1983;308:261-3.
123. Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987;316:707-10.
124. Logan RF, Edmond M, Somerville KW, Langman MJ. Smoking and ulcerative colitis. Br Med J Clin Res 1984; 288:751-3.
125. Silverstein MD, Lashner BA, Hanauer SB. Cigarette smoking and ulcerative colitis: a case-control study. Mayo Clin Proc 1994;69:425-9.
126. Persson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco smoke-a case-control study. Gut 1990;31:1377-81.
127. Lorusso D, Leo S, Misciagna G, Guerra V. Cigarette smoking and ulcerative colitis. A case control study. Hepatogastroenterology 1989;36:202-4.
128. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J 1982;284-706.
129. Franchesi S, Panza E, La Vecchia C, Parazzini F, Decarli A, Bianchi Porro G. Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 1987;125:445-52.
130. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-54.
131. Sandler RS, Sandler DP, McDonnell CW, Wurzelmann JI. Childhood exposure to environmental tobacco smoke and the risk of ulcerative colitis. Am J Epidemiol 1992;135:603-8.
132. Merrett MN, Mortensen N, Jewell DP. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gastroenterology 1993;104:A743.
133. Roberts CJ, Diggle R. Non smoking: a feature of ulcerative colitis. Br Med J 1982;285:440.
134. Thomas GA, Rhodes J, Mani V, Williams GT, Russell MA, Feyerabend C. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995;332:988-92.
135. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811-5.
136. Lashner BA, Hanauer SB, Silverstein MD. Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials. Dig Dis Sci 1990;35:827-32.
137. Lindberg E, Tysk C, Andersson K, Järnerot G. Smoking and inflammatory bowel disease. A case control study. Gut 1988; 29:352-7.
138. Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB. Cigarette smoking in Crohn's disease. Am J Gastroenterol 1989;84:31-3.
139. Srivastava ED, Rhodes J, Avramidis P, Mayberry JF. Smoking and ulcerative colitis: a community study. Int J Colorectal Dis 1993;8:71-4.
140. Motley RJ, Rhodes J, Kay S, Morris TJ. Late presentation of ulcerative colitis in ex-smokers. Int J Colorectal Dis 1988;3: 171-5.
141. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. A case-control study. Scand J Gastroenterol 1987;22:1130-6.
142. Samuelsson SM, Ekbom A, Zack M, Helmick CG, Adami HO. Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-control study. Gut 1991;32: 1526-30.
143. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1984;19:824-30.
144. Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988;23:1147-52.
145. Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994;106:643-8.
146. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990;98:1123-8.
147. Duffy LC, Zielezny MA, Marshall JR, Weiser MM, Byers TE, Phillips JF, et al. Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med 1990;6: 161-6.
148. Tysk C, Järnerot G. Has smoking changed the epidemiology of ulcerative colitis? Scand J Gastroenterol 1992;27:508-12.
149. Katschinski B, Fingerle D, Scherbaum B, Goebell H. Oral contraceptive use and cigarette smoking in Crohn's disease. Dig Dis Sci 1993;38:1596-600.
150. Sandler RS, Wurzelmann JI, Lyles CM. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology 1992;3:374-8.
151. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and ulcerative colitis. Gastroenterology 1990;99:1032-6.
152. Logan RF, Kay CR. Oral contraception, smoking and inflammatory bowel disease-findings in the Royal College of General Practitioners Oral Contraception Study. Int J Epidemiol 1989;18:105-7.
153. Lashner BA, Hanauer SB. The absence of an association between oral contraceptive use and ulcerative colitis in patients [letter]. Gastroenterology 1991;100:1784.
154. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study. Gastroenterology 1989;97:1442-7.
155. Godet PG, May GR, Sutherland LR. A meta-analysis of the role of contraceptive agents in inflammatory bowel disease [abstract]. Gastroenterology 1994;106:A689.
156. Boyko EJ, Theis MK, Vaughan TL, Nicol-Blades B. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol 1994;140:268-78.
157. Gerstman BB, Piper JM, Freiman JP, Tomita DK, Kennedy DL, Ferguson WJ, et al. Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolism. Int J Epidemiol 1990;19:931-6.
158. Hudson M, Hutton RA, Wakefield AJ, Sawyerr AM, Pounder RE. Evidence for activation of coagulation in Crohn's disease. Blood Coag Fibrin 1992;3:773-8.
159. Vecchi M, Cattaneo M, de Franchis R, Mannuchi PM. Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res 1991;21:165-70.
160. Wakefield AJ, Dhillon AP, Rowles PM, Sawyerr AM, Pittilo RM, Lewis AAM, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989;2: 1057-62.
161. Wakefield AJ, Sawyerr AM, Hudson M, Dhillon AP, Pounder RE. Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 1991;36:1147-50.
162. Wakefield AJ, Sankey EA, Dhillon AP, Sawyerr AM, More L, Sim R, et al. Granulomatous vasculitis in Crohn's disease. Gastroenterology 1991;100:1279-87.
163. Miller B, Goldstein G, Murphy M, Ginns LC. Reversible alterations in immunoregulatory T cells in smoking; analysis by monoclonal antibodies and flow cytometry. Chest 1982; 82:526-9.
164. Cope GF, Heatly RV, Kelleher JK. Smoking and colonic mucus in ulcerative colitis. Br Med J 1986;293:481.
165. Tardif J, Borgeat P, Laviolette M. Inhibition of human alveolar macrophage production of leukotriene B4 by acute in vitro and in vivo exposure to tobacco smoke. Am J Resp Cell Mol Biol 1990;2:155-61.
166. Yamaguchi E, Okazi N, Itoh A, Abe S, Kawakami Y, Okuyama H. Interleukin-1 production by alveolar macrophages is decreased in smokers. Am Rev Resp Dis 1989; 140:397-402.
167. Noble RC, Penny BB. Comparison of leucocyte count and function in smoking and non-smoking young men. Infect Immun 1975;12:550-5.
168. Srivastava ED, Barton JR, O'Mahony S, Phillips DI, Williams GT, Matthews N, et al. Smoking, humoral immunity, and ulcerative colitis. Gut 1991;32:1016-9.
169. Crotty B. Ulcerative colitis and xenobiotic metabolism. Lancet 1994;343:35-8.
170. Rachmilewitz D. Inflammatory bowel disease: concept or puzzel. In: Meyer zum Büschenfelder KH, Paumgartner C, Schölmerich J, editors. Perspectives in gastroenterology, current facts and future trends. Munich: Urban & Schwartzenberg, 1995;97-9.
171. Sullivan SN. Hypothesis revisited: toothpaste and the cause of Crohn's disease. Lancet 1990;336:1096-7.
172. Anonymous. Toothpaste and Crohn's disease [letter]. Lancet 1990;336:1580-2.
173. Anonymous. Toothpaste and Crohn's disease [letter]. Lancet 1990;336:1382.
174. Rutgeerts P, D'Haens G, Hiele M, Geboes K, Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994;106:1251-3.
175. Lindberg E, Järnerot G. The incidence of Crohn's disease is not decreasing in Sweden. Scand J Gastroenterol 1991;26: 495-500.
176. Tysk C, Järnerot G. Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963-1987. Scand J Gastroenterol 1992;27:945-50.
177. Lee FI, Nguyen-Van-Tam S. Prospective study of incidence of Crohn's disease in northwest England: no increase since the late 1970's. Eur J Gastroenterol Hepatol 1994;6:27-31.
178. Rose JD, Roberts GM, Williams G, Mayberry JF, Rhodes J. Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut 1988;29:346-51.
179. Shivananda S, Pena AS, Nap M, Weterman IT, Mayberry JF, Ruitenberg EJ, et al. Epidemiology of Crohn's disease in Regio Leiden, The Netherlands. A population study from 1979 to 1983. Gastroenterology 1987;93:966-74.
180. Brown JS, Humphreys WG, Parks TG. Some clinical aspects of Crohn's disease in Northern Ireland: an aid to earlier diagnosis? [see comments]. J R Coll Gen Pract 1988;38: 549-51.
181. Russel MGVM, Brummer R, Limonard C, Dorant E, Stockbrugger R. Incidence and prevalence of inflammatory bowel disease in South Limburg, The Netherlands. Neth J Med 1994;45:A32.
182. Gower Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994;35:1433-8.
183. Goebell H, Dirks E, Förster S, Strey B, Quebe-Fehling E. A prospective analysis of the incidence and prevalence of Crohn's disease in an urban population in Germany. Eur J Gastroenterol Hepatol 1994;6:1039-46.
184. Dirks E, Forster S, Thom M, Quebe Fehling E, Goebell H. Prospektive Untersuchung von Inzidenz und Pravalenz der Colitis ulcerosa in einer Grossstadtbevolkerung in Deutschland (Westliches Ruhrgebiet). Z Gastroenterol 1994;32:332-7.
185. Trallori G, D'Albasio G, Palli D, Bardazzi G, Cipriani F, Frittelli G, et al. Epidemiology of inflammatory bowel disease over a 10-year period in Florence (1978-1987). Ital J Gastroenterol 1991;23:559-63.
186. Delcore R, Eisenach JB, Payne KM, Bhatia P, Forster J. Risk of occult carcinomas in patients undergoing orthotopic liver transplantation for end-stage liver disease secondary to primary sclerosing cholangitis. Transplant Proc 1993;25:1883-4.
187. Baron TH, Truss CD, Elson CO. Low-dose oral methotrexate in refractory inflammatory bowel disease. Dig Dis Sci 1993; 38:1851-6.
188. Tsianos EV, Masalas CN, Merkouropoulos M, Dalekos GN, Logan RF. Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common. Gut 1994;35:369-72.
189. Odes HS, Fraser D, Krawiec J. Ulcerative colitis in the Jewish population of southern Israel 1961-1985: epidemiological and clinical study. Gut 1987;28:1630-6.
190. Gollop JH, Phillips SF, Melton LJ, Zinsmeister AR. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988;29: 49-56.